PFIZER INC — Director's Dealing 2012

Jun 8, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2012-06-01

Reporting Person: YOUNG JOHN D (Business Unit President)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	66539.0000	Direct
Common Stock	1215.0000	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to buy)	$25.8700	2017-02-21	Common Stock (41700.0000)		Direct
Employee Stock Option (right to buy)	$26.2000	2016-02-22	Common Stock (31500.0000)		Direct
Employee Stock Option (right to buy)	$26.2000	2015-02-23	Common Stock (21600.0000)		Direct
Employee Stock Option (right to buy)	$29.3300	2013-02-26	Common Stock (22950.0000)		Direct
Employee Stock Option (right to buy)	$37.1500	2014-02-25	Common Stock (29300.0000)		Direct
Stock Appreciation Rights	$12.7000	2014-02-26	Common Stock (39677.0000)		Direct
Stock Appreciation Rights	$17.6900	2015-02-25	Common Stock (49364.0000)		Direct
Stock Appreciation Rights	$18.1900	2014-12-31	Common Stock (26767.0000)		Direct
Stock Appreciation Rights	$18.9000	2016-02-24	Common Stock (52570.0000)		Direct
Stock Appreciation Rights	$18.9000	2018-02-24	Common Stock (43520.0000)		Direct
Stock Appreciation Rights	$21.0300	2017-02-23	Common Stock (51578.0000)		Direct
Stock Appreciation Rights	$21.0300	2019-02-23	Common Stock (43724.0000)		Direct
Stock Appreciation Rights	$22.5500	2013-02-28	Common Stock (23135.0000)		Direct

Footnotes

F1: These options are fully exercisable.

F2: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.

F3: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant.